Hubert Truebel

931 total citations
44 papers, 527 citations indexed

About

Hubert Truebel is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hubert Truebel has authored 44 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 9 papers in Cardiology and Cardiovascular Medicine and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hubert Truebel's work include Pulmonary Hypertension Research and Treatments (7 papers), Respiratory Support and Mechanisms (5 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Hubert Truebel is often cited by papers focused on Pulmonary Hypertension Research and Treatments (7 papers), Respiratory Support and Mechanisms (5 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Hubert Truebel collaborates with scholars based in Germany, United States and United Kingdom. Hubert Truebel's co-authors include Thomas Mondritzki, Philip Boehme, Jan P. Ehlers, Stylianos Kavadias, Fangfang Liu, Chen Wang, Juergen Pauluhn, Wenli Li, Arne Hansen and John A. Hickman and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hubert Truebel

43 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hubert Truebel Germany 15 133 108 72 55 48 44 527
Marika Vezzoli Italy 15 80 0.6× 94 0.9× 54 0.8× 48 0.9× 23 0.5× 52 706
Ryan G. Short United States 13 61 0.5× 68 0.6× 59 0.8× 43 0.8× 21 0.4× 24 693
Paul Grant United Kingdom 17 65 0.5× 95 0.9× 46 0.6× 88 1.6× 73 1.5× 69 1.1k
Qiqi Wang China 14 144 1.1× 170 1.6× 66 0.9× 67 1.2× 48 1.0× 84 786
Ahmad Al‐Azayzih Jordan 17 98 0.7× 288 2.7× 47 0.7× 30 0.5× 36 0.8× 42 793
Emily J. Cox United States 10 54 0.4× 153 1.4× 74 1.0× 41 0.7× 14 0.3× 31 605
Claude Schmitt United Kingdom 13 64 0.5× 206 1.9× 90 1.3× 48 0.9× 57 1.2× 31 772
Zijun Zhou China 18 63 0.5× 236 2.2× 62 0.9× 28 0.5× 29 0.6× 72 756
Andrew Wen United States 18 108 0.8× 278 2.6× 32 0.4× 44 0.8× 80 1.7× 64 875

Countries citing papers authored by Hubert Truebel

Since Specialization
Citations

This map shows the geographic impact of Hubert Truebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hubert Truebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hubert Truebel more than expected).

Fields of papers citing papers by Hubert Truebel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hubert Truebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hubert Truebel. The network helps show where Hubert Truebel may publish in the future.

Co-authorship network of co-authors of Hubert Truebel

This figure shows the co-authorship network connecting the top 25 collaborators of Hubert Truebel. A scholar is included among the top collaborators of Hubert Truebel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hubert Truebel. Hubert Truebel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Truebel, Hubert, et al.. (2023). Critical path activities in clinical trial setup and conduct: How to avoid bottlenecks and accelerate clinical trials. Drug Discovery Today. 28(10). 103733–103733. 3 indexed citations
2.
Boehme, Philip, et al.. (2023). Reasons for supply side driven drug shortages – A mixed-methods study on first-level, higher-level, and root causes from the perspective of marketing authorization holders. Research in Social and Administrative Pharmacy. 19(8). 1218–1227. 4 indexed citations
3.
Boehme, Philip, et al.. (2023). Sustainability in the pharmaceutical industry—An assessment of sustainability maturity and effects of sustainability measure implementation on supply chain security. Corporate Social Responsibility and Environmental Management. 31(1). 224–242. 14 indexed citations
4.
5.
Scannell, Jack W., Jim Bosley, John A. Hickman, et al.. (2022). Predictive validity in drug discovery: what it is, why it matters and how to improve it. Nature Reviews Drug Discovery. 21(12). 915–931. 47 indexed citations
6.
Hahn, Michael G., Martina Delbeck, Lisa Dietz, et al.. (2022). Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC. Respiratory Research. 23(1). 272–272. 10 indexed citations
7.
Truebel, Hubert, et al.. (2021). Social media mining in drug development—Fundamentals and use cases. Drug Discovery Today. 26(12). 2871–2880. 9 indexed citations
8.
Schwager, Emma, Sonja Schiffer, Yale Chang, et al.. (2021). Utilizing machine learning to improve clinical trial design for acute respiratory distress syndrome. npj Digital Medicine. 4(1). 133–133. 19 indexed citations
9.
Mondritzki, Thomas, Julia Vogel, Elisabeth Pook, et al.. (2020). Cardiac output improvement by pecavaptan: a novel dual‐acting vasopressin V1a/V2 receptor antagonist in experimental heart failure. European Journal of Heart Failure. 23(5). 743–750. 18 indexed citations
10.
Truebel, Hubert, et al.. (2020). Danger in the Valley of Death: how the transition from preclinical research to clinical trials can impact valuations. Drug Discovery Today. 25(12). 2089–2094. 7 indexed citations
11.
Hansen, Arne, Jan P. Ehlers, Thomas Mondritzki, et al.. (2019). Perception of the Progressing Digitization and Transformation of the German Health Care System Among Experts and the Public: Mixed Methods Study. JMIR Public Health and Surveillance. 5(4). e14689–e14689. 24 indexed citations
12.
Boehme, Philip, et al.. (2019). Digital Competencies and Attitudes Toward Digital Adherence Solutions Among Elderly Patients Treated With Novel Anticoagulants: Qualitative Study. Journal of Medical Internet Research. 22(1). e13077–e13077. 15 indexed citations
13.
Truebel, Hubert, Philip Boehme, Sven Schmiedl, et al.. (2019). A proof-of-concept trial of HELIOX with different fractions of helium in a human study modeling upper airway obstruction. European Journal of Applied Physiology. 119(5). 1253–1260. 4 indexed citations
14.
Boehme, Philip, et al.. (2018). Digital Transformation and Disruption of the Health Care Sector: Internet-Based Observational Study. Journal of Medical Internet Research. 20(3). e104–e104. 68 indexed citations
15.
Boehme, Philip, Arne Hansen, Ronenn Roubenoff, et al.. (2018). How soon will digital endpoints become a cornerstone for future drug development?. Drug Discovery Today. 24(1). 16–19. 20 indexed citations
16.
Mondritzki, Thomas, Philip Boehme, Julia Vogel, et al.. (2017). New pulmonary hypertension model in conscious dogs to investigate pulmonary-selectivity of acute pharmacological interventions. European Journal of Applied Physiology. 118(1). 195–203. 5 indexed citations
17.
Pimenta, Eduardo, Markus Jensen, David Jung, et al.. (2017). Abstract 15196: A Novel Balanced Dual Vasopressin V1a/V2 Receptor Antagonist for Treatment of Congestive Heart Failure: Results From a First-in-Man Study. Circulation. 1 indexed citations
18.
Mondritzki, Thomas, Philip Boehme, Daniel Schock‐Kusch, et al.. (2017). Transcutaneous glomerular filtration rate measurement in a canine animal model of chronic kidney disease. Journal of Pharmacological and Toxicological Methods. 90. 7–12. 6 indexed citations
19.
Raat, Nicolaas J.H., Diana M. Tabima, Patricia A. C. Specht, et al.. (2013). Direct sGC Activation Bypasses NO Scavenging Reactions of Intravascular Free Oxy-Hemoglobin and Limits Vasoconstriction. Antioxidants and Redox Signaling. 19(18). 2232–2243. 22 indexed citations
20.
Maegele, Marc, Stephan Störkel, Florian Kipfmueller, et al.. (2010). Pharyngeal Selective Brain Cooling Is Associated with Reduced CNS Cortical Lesion after Experimental Traumatic Brain Injury in Rats. Journal of Neurotrauma. 27(12). 2245–2254. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marika Vezzoli Breakdown of academic impact, for papers by Ryan G. Short Breakdown of academic impact, for papers by Paul Grant Breakdown of academic impact, for papers by Qiqi Wang Breakdown of academic impact, for papers by Ahmad Al‐Azayzih Breakdown of academic impact, for papers by Emily J. Cox Breakdown of academic impact, for papers by Claude Schmitt Breakdown of academic impact, for papers by Zijun Zhou Breakdown of academic impact, for papers by Andrew Wen
Rankless by CCL
2026